BioConsortia raises $15 million in funding

BioConsortia, an agricultural biotechnology company that uses a proprietary method for the selection of beneficial microbial consortia for crop improvement, has raised an additional $15 million in Series B funding. Khosla Ventures and Otter Capital participated equally in the round. This fund-raising round, along with the recent appointment of Marcus Meadows-Smith as the CEO of BioConsortia, accelerates the company’s plans to commercialize the use of microbial consortia as seed treatments and soil additives.

“There is substantial opportunity for BioConsortia to help transform agricultural production around the world,” said Marcus Meadows-Smith, BioConsortia CEO. “It’s gratifying to win the ongoing support of sophisticated investors like Khosla Ventures and Otter Capital.”

BioConsortia has developed a proprietary system that uses accelerated microbial selection and the latest genomic techniques to define products for specific crop improvement traits based on an optimum community of microbes, or consortia, that work together to increase crop yields with no genetic modification required. The system rapidly identifies the right consortia and can apply to both conventional and transgenic crops.

“At Khosla Ventures, we’re investing in companies that can have a systemic impact on food production around the world,” explained Andrew Chung, partner at Khosla Ventures who helped incubate the company out of New Zealand with technical founder Dr. Peter Wigley. “Since providing the seed investment in the BioConsortia technology, we’ve been strong believers in the opportunity to dramatically increase agricultural production with smaller resource requirements. This R&D platform will accelerate innovation in agriculture and enable the industry to operate in even more environmentally sensitive ways.”

“It is a pleasure to invest again in the agricultural microbial industry in support of two former executives of AgraQuest, Marcus Meadows-Smith and Christina Huben,” said John Pasquesi, managing member of Otter Capital LLC and former chairman of the board of AgraQuest. “The combination of a growing industry, BioConsortia’s differentiated technology, and management’s demonstrated record of success make this a compelling opportunity.”

In addition to product development and commercialization, BioConsortia will use the funds to invest in the necessary resources to build collaborative partnerships with seed, fertilizer and crop production companies.

For more information:
BioConsortia
1940 Research Park Drive
Suite 200
Davis, California 95618
+ 1 (530) 564-5570
info@bioconsortia.com
bioconsortia.com